Publications by authors named "Nairong Xie"
Article Synopsis
- The study explored the safety of COVID-19 vaccines for patients with Myasthenia Gravis (MG) and examined factors affecting MG exacerbation after COVID-19 infection.
- Among the 1013 adult MG patients surveyed, only a small percentage experienced exacerbation following vaccination, while a notable number faced exacerbation after COVID-19 infection, particularly those with generalized MG.
- The findings suggest that COVID-19 vaccines are generally safe for MG patients in stable condition, but those with generalized MG may be at higher risk for exacerbation following infection.
Background: The environmental effects on the prognosis of ocular myasthenia gravis (OMG) remain largely unexplored.
Aim: To investigate the association between specific environmental factors and the generalization of OMG.
Design: The cohort study was conducted in China based on a nationwide multicenter database.
Comparison between mono-tacrolimus and mono-glucocorticoid in the treatment of myasthenia gravis.
Ann Clin Transl Neurol
April 2023
Objective: Use of tacrolimus in mild to moderate myasthenia gravis (MG) is generally limited to glucocorticoid-refractory cases; the advantage of mono-tacrolimus over mono-glucocorticoids is unknown.
Methods: We included mild to moderate MG patients treated with mono-tacrolimus (mono-TAC) or mono-glucocorticoids (mono-GC). The correlation between the immunotherapy options and the treatment efficacy and side effects were examined in 1:1 propensity-score matching.